Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Taha Sethjiwala"'
Publikováno v:
IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain. 8:51-56
Nasopharyngeal carcinoma (NPC) is a rare type of tumor which arises from the surface and lining epithelium of nasopharynx. Management of nasopharyngeal carcinoma is one of the greatest clinical challenges but it is radiosensitive and chemosensitive;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16a055153d05fb673d8a61516f38ee13
https://doi.org/10.18231/j.ijashnb.2022.013
https://doi.org/10.18231/j.ijashnb.2022.013
Autor:
Geetha Senguttuvan, Shirley Sundersingh, Manikandan Dhanushkodi, Trivadi S. Ganesan, Archit Joshi, Hemanth Raj, Selvaluxmy Ganesarajah, Arun Kumar Rajan, Priya Iyer, Nikita Mehra, Gangothri Selvarajan, Sridevi Velusamy, Taha Sethjiwala, Jayachandran Perumal Kalaiarasi, Venkatraman Radhakrishnan, Arvind Krishnamurthy, Tenali Gnana Sagar, Rama Ranganathan, Bharathi Srilatha, Balasubramanian Ananthi
Publikováno v:
Indian Journal of Gynecologic Oncology. 17
The standard duration of adjuvant trastuzumab is 1 year. But the decision to use for 1 year was chosen arbitrarily in clinical trials. Many patients from developing countries like India cannot afford 1 year of adjuvant trastuzumab. We retrospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8856a6a580de74e4d748c63889fdfed9
https://doi.org/10.1007/s40944-019-0313-2
https://doi.org/10.1007/s40944-019-0313-2
Autor:
Geetha Senguttuvan, Trivadi S. Ganesan, Manikandan Dhanushkodi, Arun Kumar Rajan, Jayachandran Perumal Kalaiarasi, Priya Iyer, Nikita Mehra, Arvind Krishnamurthy, Gangothri Selvarajan, Tenali Gnana Sagar, Selvaluxmy Ganesarajah, Venkatraman Radhakrishnan, Bharathi Srilatha, Sridevi Velusamy, Taha Sethjiwala, Balasubramanian Ananthi, Archit Joshi
Publikováno v:
Indian Journal of Gynecologic Oncology. 17
There is no standard chemotherapy for patients with MBC who progress after exposure to anthracycline and taxane. We conducted this study to assess the outcome of patients who were treated with eribulin. This was a retrospective study of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2da1cc34ae6dcffcf798f7714b83473e
https://doi.org/10.1007/s40944-019-0301-6
https://doi.org/10.1007/s40944-019-0301-6